We do not have full text access to this journal. Please contact the library to order articles via interlibrary loan.
Self - Monitoring of Blood Glucose ( SMBG ) in Insulin - and Non - Insulin - Using Adults with Diabetes : Consensus Recommendations for Improving SMBG Accuracy , Utilization , and Research
Hirsch , Irl B . ; Bode , Bruce W ; Childs , Belinda P . ; Close , Kelly L . ; Fisher , William A . ; Gavin , James R . ; Ginsberg , Barry H . ; Raine , Charles H . ; Verderese , Carol A .
Page: 419-439 Vol/Issue: 2008 ; VOL 10 ; PART 6 Date: 2008/12/01
Bolus Calculator : A Review of Four " Smart " Insulin Pumps
Zisser , Howard ; Robinson , Lauren ; Bevier , Wendy ; Dassau , Eyal ; Ellingsen , Christian ; Doyle , Francis J . ; Jovanovic , Lois
Page: 441-444 Vol/Issue: 2008 ; VOL 10 ; PART 6 Date: 2008/12/01
Assessing the Performance of Handheld Glucose Testing for Critical Care
Kost , Gerald J . ; Tran , Nam K . ; Louie , Richard F . ; Gentile , Nicole L . ; Abad , Victor J
Page: 445-451 Vol/Issue: 2008 ; VOL 10 ; PART 6 Date: 2008/12/01
Preclinical In Vivo Study of a Fluorescence Affinity Sensor for Short - Term Continuous Glucose Monitoring in a Small and Large Animal Model
Dutt - Ballerstadt , Ralph ; Evans , Colton ; Gowda , Ashok ; McNichols , Roger
Page: 453-460 Vol/Issue: 2008 ; VOL 10 ; PART 6 Date: 2008/12/01
Diabetes Distress and Its Association with Clinical Outcomes in Patients with Type 2 Diabetes Treated with Pramlintide as an Adjunct to Insulin Therapy
Peyrot , Mark ; Rubin , Richard R ; Polonsky , William H .
Page: 461-466 Vol/Issue: 2008 ; VOL 10 ; PART 6 Date: 2008/12/01
Standardized Evaluation of Nine Instruments for Self - Monitoring of Blood Glucose
Kristensen , Gunn B . B . ; Monsen , Grete ; Skeie , Svein ; Sandberg , Sverre
Page: 467-477 Vol/Issue: 2008 ; VOL 10 ; PART 6 Date: 2008/12/01
The Pharmacokinetic and Pharmacodynamic Properties of Different Formulations of Biphasic Insulin Aspart : A Randomized , Glucose Clamp , Crossover Study
Heise , T . ; Eckers , U . ; Kanc , K . ; Nielsen , J . N . ; Nosek , L .
Page: 479-485 Vol/Issue: 2008 ; VOL 10 ; PART 6 Date: 2008/12/01
Skin Heat Dissipation : The Influence of Diabetes , Skin Thickness , and Subcutaneous Fat Thickness
Petrofsky , Jerrold S . ; McLellan , Katie ; Bains , Gurinder S . ; Prowse , Michelle ; Ethiraju , Gomathi ; Lee , Scott ; Gunda , Shashi ; Lohman , Everett ; Schwab , Ernie
Page: 487-493 Vol/Issue: 2008 ; VOL 10 ; PART 6 Date: 2008/12/01
Better Postprandial Glucose Stability During Continuous Subcutaneous Infusion with Insulin Aspart Compared with Insulin Lispro in Patients with Type 1 Diabetes
Bartolo , Paolo Di ; Pellicano , Francesca ; Scaramuzza , Antonio ; Sardu , Cipriana ; Casetti , Tino ; Bosi , Emanuele ; Miselli , Valerio ; Br and olini , Sara ; Fabbri , Tiziano ; Me and ri , Piero ; Cannatá ; a , Francesco
Page: 495-498 Vol/Issue: 2008 ; VOL 10 ; PART 6 Date: 2008/12/01
Proceedings and Short Reports of an International Symposium on SMBG , Italy , May 2008
Alzaid , Aus ; Khamseh , Mohammad E .
Page: 499-505 Vol/Issue: 2008 ; VOL 10 ; PART 6 Date: 2008/12/01
The Poincarâ ; e Plot , but Not the Correlation R Value , Is a Good Marker of Temporal Variability of CGMS Data
Molnâ ; ar , Gergè ; o A . ; Boros , Andrâ ; as G . ; Pâ ; otâ ; o , Lâ ; aszlâ ; o ; Tamaskâ ; o , Mâ ; onika ; Wittmann , Istvâ ; an
Page: 506-507 Vol/Issue: 2008 ; VOL 10 ; PART 6 Date: 2008/12/01
Correction
Page: 508 Vol/Issue: 2008 ; VOL 10 ; PART 6 Date: 2008/12/01
This week's Diabetes Bulletin...
...
Showing posts with label self monitoring. Show all posts
Showing posts with label self monitoring. Show all posts
Friday, 30 January 2009
Friday, 7 November 2008
Diabetes, Obesity and Metabolism Vol. 10, Iss. 12, 2008.
We do not have full text access to this journal. Please contact the library to order articles via interlibrary loan.
Pages: 1135-1156
Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women
Szalat Auryan, Raz Itamar
http://www3.interscience.wiley.com/cgi-bin/abstract/120125640/ABSTRACT
Pages: 1157-1166
The role of renin–angiotensin–aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection
Hussam Abuissa, James O'Keefe Jr
http://www3.interscience.wiley.com/cgi-bin/abstract/120125642/ABSTRACT
Pages: 1167-1177
Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes
P. Raskin
http://www3.interscience.wiley.com/cgi-bin/abstract/120125648/ABSTRACT
Pages: 1178-1185
Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs
M. R. Lankisch, K. C. Ferlinz, J. L. Leahy, W. A. Scherbaum
http://www3.interscience.wiley.com/cgi-bin/abstract/121494348/ABSTRACT
Pages: 1186-1194
Persistence of improvement in insulin sensitivity following a dietary weight loss programme
T. McLaughlin, P. Schweitzer, S. Carter, C.-G. Yen, C. Lamendola, F. Abbasi, G. Reaven
http://www3.interscience.wiley.com/cgi-bin/abstract/120125630/ABSTRACT
Pages: 1195-1203
Weight loss in obese men by caloric restriction and high-dose diazoxide–mediated insulin suppression
G. van Boekel, S. Loves, A. van Sorge, J. Ruinemans-Koerts, T. Rijnders, H. de Boer
http://www3.interscience.wiley.com/cgi-bin/abstract/120125631/ABSTRACT
Pages: 1204-1211
Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients
Y. Miyazaki, R. A. DeFronzo
http://www3.interscience.wiley.com/cgi-bin/abstract/120125633/ABSTRACT
Pages: 1212-1220
Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach
L. Xu, C. Dalla Man, B. Charbonnel, G. Meninger, M. J. Davies, D. Williams-Herman, C. Cobelli, P. P. Stein
http://www3.interscience.wiley.com/cgi-bin/abstract/120125634/ABSTRACT
Pages: 1221-1238
Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trials
E. Mannucci, M. Monami, C. Lamanna, G. F. Gensini, N. Marchionni
http://www3.interscience.wiley.com/cgi-bin/abstract/120125638/ABSTRACT
Pages: 1239-1247
The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release–based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study)
A. H. Barnett, A. J. Krentz, K. Strojek, J. Sieradzki, F. Azizi, M. Embong, S. Imamoglu, J. Peru i ovß, V. Uli iansky, G. Winkler
http://www3.interscience.wiley.com/cgi-bin/abstract/120125639/ABSTRACT
Pages: 1248-1260
PROCEED: Prospective Obesity Cohort of Economic Evaluation and Determinants: baseline health and healthcare utilization of the US sample*
A. M. Wolf, N. Finer, A. A. Allshouse, K. B. Pendergast, B. H. Sherrill, I. Caterson, J. O. Hill, L. J. Aronne, H. Hauner, C. Radigue, C. Amand, J.-P. Despres
http://www3.interscience.wiley.com/cgi-bin/abstract/121384113/ABSTRACT
Pages: 1261-1265
Comparison of twice-daily injections of biphasic insulin lispro and basal-bolus therapy: glycaemic control and quality-of-life of insulin-naïve type 2 diabetic patients
H. Masuda, M. Sakamoto, J. Irie, A. Kitaoka, K. Shiono, G. Inoue, K. Atsuda, S. Yamada
http://www3.interscience.wiley.com/cgi-bin/abstract/120125641/ABSTRACT
Pages: 1266-1270
Increase in high molecular weight adiponectin by bariatric surgery-induced weight loss
P. Linscheid, M. Christ-Crain, R. Stoeckli, C. E. Reusch, T. A. Lutz, B. Mⁿller, U. Keller
http://www3.interscience.wiley.com/cgi-bin/abstract/120125643/ABSTRACT
Pages: 1271-1274
Fatty acid synthase inhibitor, C75, blocks resistin-induced increases in lipid accumulation by human macrophages
C. Rae, A. Graham
http://www3.interscience.wiley.com/cgi-bin/abstract/121494350/ABSTRACT
Pages: 1275-1276
Prolonged thiazolidinedione therapy does not reverse fat loss in patients with familial partial lipodystrophy, Dunnigan variety
V. Simha, S. Rao, A. Garg
http://www3.interscience.wiley.com/cgi-bin/abstract/121494349/ABSTRACT
Pages: 1135-1156
Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women
Szalat Auryan, Raz Itamar
http://www3.interscience.wiley.com/cgi-bin/abstract/120125640/ABSTRACT
Pages: 1157-1166
The role of renin–angiotensin–aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection
Hussam Abuissa, James O'Keefe Jr
http://www3.interscience.wiley.com/cgi-bin/abstract/120125642/ABSTRACT
Pages: 1167-1177
Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes
P. Raskin
http://www3.interscience.wiley.com/cgi-bin/abstract/120125648/ABSTRACT
Pages: 1178-1185
Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs
M. R. Lankisch, K. C. Ferlinz, J. L. Leahy, W. A. Scherbaum
http://www3.interscience.wiley.com/cgi-bin/abstract/121494348/ABSTRACT
Pages: 1186-1194
Persistence of improvement in insulin sensitivity following a dietary weight loss programme
T. McLaughlin, P. Schweitzer, S. Carter, C.-G. Yen, C. Lamendola, F. Abbasi, G. Reaven
http://www3.interscience.wiley.com/cgi-bin/abstract/120125630/ABSTRACT
Pages: 1195-1203
Weight loss in obese men by caloric restriction and high-dose diazoxide–mediated insulin suppression
G. van Boekel, S. Loves, A. van Sorge, J. Ruinemans-Koerts, T. Rijnders, H. de Boer
http://www3.interscience.wiley.com/cgi-bin/abstract/120125631/ABSTRACT
Pages: 1204-1211
Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients
Y. Miyazaki, R. A. DeFronzo
http://www3.interscience.wiley.com/cgi-bin/abstract/120125633/ABSTRACT
Pages: 1212-1220
Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach
L. Xu, C. Dalla Man, B. Charbonnel, G. Meninger, M. J. Davies, D. Williams-Herman, C. Cobelli, P. P. Stein
http://www3.interscience.wiley.com/cgi-bin/abstract/120125634/ABSTRACT
Pages: 1221-1238
Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trials
E. Mannucci, M. Monami, C. Lamanna, G. F. Gensini, N. Marchionni
http://www3.interscience.wiley.com/cgi-bin/abstract/120125638/ABSTRACT
Pages: 1239-1247
The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release–based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study)
A. H. Barnett, A. J. Krentz, K. Strojek, J. Sieradzki, F. Azizi, M. Embong, S. Imamoglu, J. Peru i ovß, V. Uli iansky, G. Winkler
http://www3.interscience.wiley.com/cgi-bin/abstract/120125639/ABSTRACT
Pages: 1248-1260
PROCEED: Prospective Obesity Cohort of Economic Evaluation and Determinants: baseline health and healthcare utilization of the US sample*
A. M. Wolf, N. Finer, A. A. Allshouse, K. B. Pendergast, B. H. Sherrill, I. Caterson, J. O. Hill, L. J. Aronne, H. Hauner, C. Radigue, C. Amand, J.-P. Despres
http://www3.interscience.wiley.com/cgi-bin/abstract/121384113/ABSTRACT
Pages: 1261-1265
Comparison of twice-daily injections of biphasic insulin lispro and basal-bolus therapy: glycaemic control and quality-of-life of insulin-naïve type 2 diabetic patients
H. Masuda, M. Sakamoto, J. Irie, A. Kitaoka, K. Shiono, G. Inoue, K. Atsuda, S. Yamada
http://www3.interscience.wiley.com/cgi-bin/abstract/120125641/ABSTRACT
Pages: 1266-1270
Increase in high molecular weight adiponectin by bariatric surgery-induced weight loss
P. Linscheid, M. Christ-Crain, R. Stoeckli, C. E. Reusch, T. A. Lutz, B. Mⁿller, U. Keller
http://www3.interscience.wiley.com/cgi-bin/abstract/120125643/ABSTRACT
Pages: 1271-1274
Fatty acid synthase inhibitor, C75, blocks resistin-induced increases in lipid accumulation by human macrophages
C. Rae, A. Graham
http://www3.interscience.wiley.com/cgi-bin/abstract/121494350/ABSTRACT
Pages: 1275-1276
Prolonged thiazolidinedione therapy does not reverse fat loss in patients with familial partial lipodystrophy, Dunnigan variety
V. Simha, S. Rao, A. Garg
http://www3.interscience.wiley.com/cgi-bin/abstract/121494349/ABSTRACT
Friday, 24 October 2008
Diabetes Care VOL 31 ; PART 10
We have full text access to thsi journal. Click here for access. You will need an NHS Athens password.
Pancreas Histology and a Longitudinal Study of Insulin Secretion in a Japanese Patient With Latent Autoimmune Diabetes in Adults
Satoshi Murao
Page: e69 - e69 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Bent Needles : Another Problem in Glycemic Control
Antonio C . Bossi
Page: e70 - e70 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Predictive Value of Postoperative Glycosuria After Partial Elective Pancreatectomy in Focal Congenital Hyperinsulinism
Naziha Khen - Dunlop
Page: e71 - e71 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Elevated Plasma Plasminogen Activator Inhibitor - 1 in CD36 Deficiency
Hidekatsu Yanai
Page: e72 - e72 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Self - Monitoring of Blood Glucose , Cutaneous Finger Injury , and Sensory Loss in Diabetic Patients
Jean - Pierre Le Floch
Page: e73 - e73 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Prediction of Mortality Using Measures of Cardiac Autonomic Dysfunction in the Diabetic and Nondiabetic Population : The MONICA / KORA Augsburg Cohort Study : Response to Ziegler et al .
Vaibhav Salvi
Page: e74 - e74 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Prediction of Mortality Using Measures of Cardiac Autonomic Dysfunction in the Diabetic and Nondiabetic Population : The MONICA / KORA Augsburg Cohort Study : Response to Salvi et al .
Dan Ziegler
Page: e75 - e75 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Comparison of Negative Pressure Wound Therapy Using Vacuum - Assisted Closure With Advanced Moist Wound Therapy in the Treatment of Diabetic Foot Ulcers : A Multicenter Randomized Controlled Trial : Response to Blume et al
Lars G . Hemkens
Page: e76 - e76 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Comparison of Negative Pressure Wound Therapy Using Vacuum - Assisted Closure With Advanced Moist Wound Therapy in the Treatment of Diabetic Foot Ulcers : a Multicenter Randomized Controlled Trial : Response to Hemkens and Waltering
Peter A Blume
Page: e77 - e77 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Prognostic Value of the Insertion / Deletion Polymorphism of the ACE Gene in Type 2 Diabetic Subjects : Results From the Non - Insulin - Dependent Diabetes , Hypertension , Microalbuminuria or Proteinuria , Cardiovascular Events , and Ramipril ( DIABHYCAR ) , Diabete de type 2 , Nephropathie et Genetique ( DIAB2NEPHROGENE ) , and Survie , Diabete de type 2 et Genetique ( SURDIAGENE ) Studies : Res
Daniel P . K . Ng
Page: e78 - e78 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Prognostic Value of the Insertion / Deletion Polymorphism of the ACE Gene in Type 2 Diabetic Subjects : Results From the Non - Insulin - Dependent Diabetes , Hypertension , Microalbuminuria or Proteinuria , Cardiovascular Events , and Ramipril ( DIABHYCAR ) , Diabete de type 2 , Nephropathie et Genetique ( DIAB2NEPHROGENE ) , and Survie , Diabete de type 2 et Genetique ( SURDIAGENE ) Studies : Res
Samy Hadjadj
Page: e79 - e79 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Comparison of the Numerical and Clinical Accuracy of Four Continuous Glucose Monitors : Response to Kovatchev et al .
James Brauker
Page: e80 - e80 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Comparison of the Numerical and Clinical Accuracy of Four Continuous Glucose Monitors : Response to Brauker and Matsubara
Boris Kovatchev
Page: e81 - e81 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Cross - Sectional and Prospective Study of Lung Function in Adults With Type 2 Diabetes : The Atherosclerosis Risk in Communities ( ARIC ) Study : Response to Yeh et al .
John G . Teeter
Page: e82 - e82 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Beneficial Effects of Insulin on Glycemic Control and ß - Cell Function in Newly Diagnosed Type 2 Diabetes With Severe Hyperglycemia After Short - Term Intensive Insulin Therapy
Harn - Shen Chen
Page: 1927 - 1932 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Impact of Diabetes and Its Treatment on Cognitive Function Among Adolescents Who Participated in the Diabetes Control and Complications Trial
Gail Musen
Page: 1933 - 1938 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Ser1369Ala Variant in Sulfonylurea Receptor Gene ABCC8 Is Associated With Antidiabetic Efficacy of Gliclazide in Chinese Type 2 Diabetic Patients
Yan Feng
Page: 1939 - 1944 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
A1C but Not Serum Glycated Albumin Is Elevated in Late Pregnancy Owing to Iron Deficiency
Kunihiko Hashimoto
Page: 1945 - 1948 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Reduced Progression to Type 2 Diabetes From Impaired Glucose Tolerance After a 2 - Day In - Hospital Diabetes Educational Program : The Joetsu Diabetes Prevention Trial
Tetsuya Kawahara
Page: 1949 - 1954 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Can Admission and Fasting Glucose Reliably Identify Undiagnosed Diabetes in Patients With Acute Coronary Syndrome ?
Onyebuchi E . Okosieme
Page: 1955 - 1959 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Weight Change in Diabetes and Glycemic and Blood Pressure Control
Adrianne C . Feldstein
Page: 1960 - 1965 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Mixed - Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of ß - Cell Function in Therapeutic Trials in Type 1 Diabetes
Carla J . Greenbaum
Page: 1966 - 1971 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Antecedent Hyperglycemia Is Associated With an Increased Risk of Neutropenic Infections During Bone Marrow Transplantation
Rachel L . Derr
Page: 1972 - 1977 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Prediction of the Onset of Disturbed Eating Behavior in Adolescent Girls With Type 1 Diabetes
Marion P . Olmsted
Page: 1978 - 1982 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Superior Mesenteric Artery Syndrome in Type 1 Diabetes Masquerading as Gastroparesis
Luigi F . Meneghini
Page: 1983 - 1984 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Timing Is Everything : Age of Onset Influences Long - Term Retinopathy Risk in Type 2 Diabetes , Independent of Traditional Risk Factors
Jencia Wong
Page: 1985 - 1990 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Effect of Aging on A1C Levels in Individuals Without Diabetes : Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001 - 2004
Lydie N . Pani
Page: 1991 - 1996 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Diabetes and Obesity - Related Risks for Pelvic Reconstructive Surgery in a Cohort of Swedish Twins
Mats Forsman
Page: 1997 - 1999 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Association of C - Reactive Protein With Reduced Forced Vital Capacity in a Nonsmoking U . S . Population With Metabolic Syndrome and Diabetes
Hwa Mu Lee
Page: 2000 - 2002 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
Jane A . Driver
Page: 2003 - 2005 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT / EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications
Maria F . Lopes - Virella
Page: 2006 - 2012 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Testosterone Concentration in Young Patients With Diabetes
Anil Chandel
Page: 2013 - 2017 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Serum Xylosyltransferase Activity in Diabetic Patients as a Possible Marker of Reduced Proteoglycan Biosynthesis
Christian G Ö tting
Page: 2018 - 2019 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Prevalence of the Metabolic Syndrome Among a Racially / Ethnically Diverse Group of U S . Eighth - Grade Adolescents and Associations With Fasting Insulin and Homeostasis Model Assessment of Insulin Resistance Levels
Page: 2020 - 2025 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Glucose Intolerance in Pregnancy and Future Risk of Pre - Diabetes or Diabetes
Ravi Retnakaran
Page: 2026 - 2031 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Changes in Triglyceride Levels Over Time and Risk of Type 2 Diabetes in Young Men
Amir Tirosh
Page: 2032 - 2037 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Risk Prediction of Cardiovascular Disease in Type 2 Diabetes : A risk equation from the Swedish National Diabetes Register
Jan Cederholm
Page: 2038 - 2043 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Changes in Risk Variables of Metabolic Syndrome Since Childhood in Pre - Diabetic and Type 2 Diabetic Subjects : The Bogalusa Heart Study
Quoc Manh Nguyen
Page: 2044 - 2049 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Alcohol Consumption , Mediating Biomarkers , and Risk of Type 2 Diabetes Among Middle - Aged Women
Joline W . J . Beulens
Page: 2050 - 2055 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Predicting Diabetes : Clinical , Biological , and Genetic Approaches : Data from the Epidemiological Study on the Insulin Resistance Syndrome ( DESIR )
Beverley Balkau
Page: 2056 - 2061 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
American College of Endocrinology Pre - Diabetes Consensus Conference : Part One
Zachary T . Bloomgarden
Page: 2062 - 2069 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
No Need for the Needle ( at First )
Mayer B . Davidson
Page: 2070 - 2071 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Glycemic Control and Hypoglycemia : Is the loser the winner ?
Lawrence C . Perlmuter
Page: 2072 - 2076 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Pancreas Histology and a Longitudinal Study of Insulin Secretion in a Japanese Patient With Latent Autoimmune Diabetes in Adults
Satoshi Murao
Page: e69 - e69 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Bent Needles : Another Problem in Glycemic Control
Antonio C . Bossi
Page: e70 - e70 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Predictive Value of Postoperative Glycosuria After Partial Elective Pancreatectomy in Focal Congenital Hyperinsulinism
Naziha Khen - Dunlop
Page: e71 - e71 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Elevated Plasma Plasminogen Activator Inhibitor - 1 in CD36 Deficiency
Hidekatsu Yanai
Page: e72 - e72 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Self - Monitoring of Blood Glucose , Cutaneous Finger Injury , and Sensory Loss in Diabetic Patients
Jean - Pierre Le Floch
Page: e73 - e73 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Prediction of Mortality Using Measures of Cardiac Autonomic Dysfunction in the Diabetic and Nondiabetic Population : The MONICA / KORA Augsburg Cohort Study : Response to Ziegler et al .
Vaibhav Salvi
Page: e74 - e74 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Prediction of Mortality Using Measures of Cardiac Autonomic Dysfunction in the Diabetic and Nondiabetic Population : The MONICA / KORA Augsburg Cohort Study : Response to Salvi et al .
Dan Ziegler
Page: e75 - e75 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Comparison of Negative Pressure Wound Therapy Using Vacuum - Assisted Closure With Advanced Moist Wound Therapy in the Treatment of Diabetic Foot Ulcers : A Multicenter Randomized Controlled Trial : Response to Blume et al
Lars G . Hemkens
Page: e76 - e76 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Comparison of Negative Pressure Wound Therapy Using Vacuum - Assisted Closure With Advanced Moist Wound Therapy in the Treatment of Diabetic Foot Ulcers : a Multicenter Randomized Controlled Trial : Response to Hemkens and Waltering
Peter A Blume
Page: e77 - e77 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Prognostic Value of the Insertion / Deletion Polymorphism of the ACE Gene in Type 2 Diabetic Subjects : Results From the Non - Insulin - Dependent Diabetes , Hypertension , Microalbuminuria or Proteinuria , Cardiovascular Events , and Ramipril ( DIABHYCAR ) , Diabete de type 2 , Nephropathie et Genetique ( DIAB2NEPHROGENE ) , and Survie , Diabete de type 2 et Genetique ( SURDIAGENE ) Studies : Res
Daniel P . K . Ng
Page: e78 - e78 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Prognostic Value of the Insertion / Deletion Polymorphism of the ACE Gene in Type 2 Diabetic Subjects : Results From the Non - Insulin - Dependent Diabetes , Hypertension , Microalbuminuria or Proteinuria , Cardiovascular Events , and Ramipril ( DIABHYCAR ) , Diabete de type 2 , Nephropathie et Genetique ( DIAB2NEPHROGENE ) , and Survie , Diabete de type 2 et Genetique ( SURDIAGENE ) Studies : Res
Samy Hadjadj
Page: e79 - e79 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Comparison of the Numerical and Clinical Accuracy of Four Continuous Glucose Monitors : Response to Kovatchev et al .
James Brauker
Page: e80 - e80 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Comparison of the Numerical and Clinical Accuracy of Four Continuous Glucose Monitors : Response to Brauker and Matsubara
Boris Kovatchev
Page: e81 - e81 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Cross - Sectional and Prospective Study of Lung Function in Adults With Type 2 Diabetes : The Atherosclerosis Risk in Communities ( ARIC ) Study : Response to Yeh et al .
John G . Teeter
Page: e82 - e82 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Beneficial Effects of Insulin on Glycemic Control and ß - Cell Function in Newly Diagnosed Type 2 Diabetes With Severe Hyperglycemia After Short - Term Intensive Insulin Therapy
Harn - Shen Chen
Page: 1927 - 1932 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Impact of Diabetes and Its Treatment on Cognitive Function Among Adolescents Who Participated in the Diabetes Control and Complications Trial
Gail Musen
Page: 1933 - 1938 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Ser1369Ala Variant in Sulfonylurea Receptor Gene ABCC8 Is Associated With Antidiabetic Efficacy of Gliclazide in Chinese Type 2 Diabetic Patients
Yan Feng
Page: 1939 - 1944 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
A1C but Not Serum Glycated Albumin Is Elevated in Late Pregnancy Owing to Iron Deficiency
Kunihiko Hashimoto
Page: 1945 - 1948 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Reduced Progression to Type 2 Diabetes From Impaired Glucose Tolerance After a 2 - Day In - Hospital Diabetes Educational Program : The Joetsu Diabetes Prevention Trial
Tetsuya Kawahara
Page: 1949 - 1954 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Can Admission and Fasting Glucose Reliably Identify Undiagnosed Diabetes in Patients With Acute Coronary Syndrome ?
Onyebuchi E . Okosieme
Page: 1955 - 1959 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Weight Change in Diabetes and Glycemic and Blood Pressure Control
Adrianne C . Feldstein
Page: 1960 - 1965 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Mixed - Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of ß - Cell Function in Therapeutic Trials in Type 1 Diabetes
Carla J . Greenbaum
Page: 1966 - 1971 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Antecedent Hyperglycemia Is Associated With an Increased Risk of Neutropenic Infections During Bone Marrow Transplantation
Rachel L . Derr
Page: 1972 - 1977 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Prediction of the Onset of Disturbed Eating Behavior in Adolescent Girls With Type 1 Diabetes
Marion P . Olmsted
Page: 1978 - 1982 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Superior Mesenteric Artery Syndrome in Type 1 Diabetes Masquerading as Gastroparesis
Luigi F . Meneghini
Page: 1983 - 1984 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Timing Is Everything : Age of Onset Influences Long - Term Retinopathy Risk in Type 2 Diabetes , Independent of Traditional Risk Factors
Jencia Wong
Page: 1985 - 1990 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Effect of Aging on A1C Levels in Individuals Without Diabetes : Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001 - 2004
Lydie N . Pani
Page: 1991 - 1996 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Diabetes and Obesity - Related Risks for Pelvic Reconstructive Surgery in a Cohort of Swedish Twins
Mats Forsman
Page: 1997 - 1999 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Association of C - Reactive Protein With Reduced Forced Vital Capacity in a Nonsmoking U . S . Population With Metabolic Syndrome and Diabetes
Hwa Mu Lee
Page: 2000 - 2002 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
Jane A . Driver
Page: 2003 - 2005 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT / EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications
Maria F . Lopes - Virella
Page: 2006 - 2012 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Testosterone Concentration in Young Patients With Diabetes
Anil Chandel
Page: 2013 - 2017 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Serum Xylosyltransferase Activity in Diabetic Patients as a Possible Marker of Reduced Proteoglycan Biosynthesis
Christian G Ö tting
Page: 2018 - 2019 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Prevalence of the Metabolic Syndrome Among a Racially / Ethnically Diverse Group of U S . Eighth - Grade Adolescents and Associations With Fasting Insulin and Homeostasis Model Assessment of Insulin Resistance Levels
Page: 2020 - 2025 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Glucose Intolerance in Pregnancy and Future Risk of Pre - Diabetes or Diabetes
Ravi Retnakaran
Page: 2026 - 2031 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Changes in Triglyceride Levels Over Time and Risk of Type 2 Diabetes in Young Men
Amir Tirosh
Page: 2032 - 2037 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Risk Prediction of Cardiovascular Disease in Type 2 Diabetes : A risk equation from the Swedish National Diabetes Register
Jan Cederholm
Page: 2038 - 2043 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Changes in Risk Variables of Metabolic Syndrome Since Childhood in Pre - Diabetic and Type 2 Diabetic Subjects : The Bogalusa Heart Study
Quoc Manh Nguyen
Page: 2044 - 2049 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Alcohol Consumption , Mediating Biomarkers , and Risk of Type 2 Diabetes Among Middle - Aged Women
Joline W . J . Beulens
Page: 2050 - 2055 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Predicting Diabetes : Clinical , Biological , and Genetic Approaches : Data from the Epidemiological Study on the Insulin Resistance Syndrome ( DESIR )
Beverley Balkau
Page: 2056 - 2061 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
American College of Endocrinology Pre - Diabetes Consensus Conference : Part One
Zachary T . Bloomgarden
Page: 2062 - 2069 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
No Need for the Needle ( at First )
Mayer B . Davidson
Page: 2070 - 2071 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Glycemic Control and Hypoglycemia : Is the loser the winner ?
Lawrence C . Perlmuter
Page: 2072 - 2076 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Friday, 10 October 2008
National electronic Library for Medicines (NeLM) Updates
National electronic Library for Medicines (NeLM): http://www.nelm.nhs.uk
· RCT: Effect of the frequency of self-monitoring blood glucose in patients with type 2 diabetes treated with oral antidiabetics http://www.nelm.nhs.uk/en/NeLM-Area/News/2008---September/08/RCT-Effect-of-the-frequency-of-self-monitoring-blood-glucose-in-patients-with-type-2-diabetes-treated-with-oral-antidiabetics/
· Horizon scanning: exenatide once-weekly non-inferior to twice daily in type 2 diabetes? http://www.nelm.nhs.uk/en/NeLM-Area/News/2008---September/08/Horizon-scanning-exenatide-once-weekly-non-inferior-to-twice-daily-in-type-2-diabetes-/
· Continuous glucose monitoring may improve outcomes in adults with type 1 diabetes http://www.nelm.nhs.uk/en/NeLM-Area/News/2008---September/09/Continuous-glucose-monitoring-may-improve-outcomes-in-adults-with-type-1-diabetes/
· Lactic acidosis with oral antidiabetic drugs: very rare, and associated with co-morbidities http://www.nelm.nhs.uk/en/NeLM-Area/News/2008---September/10/Lactic-acidosis-with-oral-antidiabetic-drugs-very-rare-and-associated-with-co-morbidities/
· Long-term outcomes of tight glycaemic and BP control in type 2 diabetes http://www.nelm.nhs.uk/en/NeLM-Area/News/2008---September/11/Long-term-outcomes-of-tight-glycaemic-and-BP-control-in-type-2-diabetes/
· Perspective: cardiovascular safety of antidiabetic drugs http://www.nelm.nhs.uk/en/NeLM-Area/News/2008---September/11/Perspective-cardiovascular-safety-of-antidiabetic-drugs/
· RCT: Effect of the frequency of self-monitoring blood glucose in patients with type 2 diabetes treated with oral antidiabetics http://www.nelm.nhs.uk/en/NeLM-Area/News/2008---September/08/RCT-Effect-of-the-frequency-of-self-monitoring-blood-glucose-in-patients-with-type-2-diabetes-treated-with-oral-antidiabetics/
· Horizon scanning: exenatide once-weekly non-inferior to twice daily in type 2 diabetes? http://www.nelm.nhs.uk/en/NeLM-Area/News/2008---September/08/Horizon-scanning-exenatide-once-weekly-non-inferior-to-twice-daily-in-type-2-diabetes-/
· Continuous glucose monitoring may improve outcomes in adults with type 1 diabetes http://www.nelm.nhs.uk/en/NeLM-Area/News/2008---September/09/Continuous-glucose-monitoring-may-improve-outcomes-in-adults-with-type-1-diabetes/
· Lactic acidosis with oral antidiabetic drugs: very rare, and associated with co-morbidities http://www.nelm.nhs.uk/en/NeLM-Area/News/2008---September/10/Lactic-acidosis-with-oral-antidiabetic-drugs-very-rare-and-associated-with-co-morbidities/
· Long-term outcomes of tight glycaemic and BP control in type 2 diabetes http://www.nelm.nhs.uk/en/NeLM-Area/News/2008---September/11/Long-term-outcomes-of-tight-glycaemic-and-BP-control-in-type-2-diabetes/
· Perspective: cardiovascular safety of antidiabetic drugs http://www.nelm.nhs.uk/en/NeLM-Area/News/2008---September/11/Perspective-cardiovascular-safety-of-antidiabetic-drugs/
Friday, 18 July 2008
Latest Diabetes News from the National Library for Health
MeReC Monthly (June 2008): Self-monitoring in type 2 diabetes
via NeLM news - Diabetes on 7/7/08
The latest edition of MeReC Monthly reviews the use of routine self-monitoring of blood glucose (SMBG), noting that two recent studies (ESMON and DiGEM economic analysis) have reinforced the view that it is unlikely to be beneficial in patients with type 2 diabetes who are not treated with insulin and may worsen quality of life and waste NHS resources. Therefore it should be reserved for patients treated with insulin and for non-insulin treated patients in specific circumstances, as recommended in recent NICE guidance on type 2 diabetes (see link).
SMC accepts restricted use of Eucreas tablets (vildagliptin 50mg + metformin 850mg or 1000mg) for type 2 diabetes
via NeLM news - Diabetes 7/7/08
Following a review of an abbreviated submission (used for new formulations at same or lesser cost, and new tablet strength or size), the Scottish Medicines Consortium (SMC) has accepted for restricted use within NHS Scotland, Eucreas® tablets (vildagliptin 50mg/metformin 850mg and vildagliptin 50mg /metformin 1000mg). ...
Meta-analysis: Pregabalin for painful diabetic neuropathy
via NeLM news - Diabetes on 6/7/08
Pregabalin is effective for treatment of painful diabetic neuropathy across its usual dose range, according to a meta-analysis sponsored by the drug's manufacturer and part-authored by company employees. A number of controlled trials have been carried out with pregabalin in patients with painful diabetic neuropathy, however they have used different dose regimens: this analysis was carried out to evaluate the drug's efficacy and safety in this condition at all effective doses....
DTB: exenatide (Byetta), sitagliptin (Januvia), and vildagliptin (Galvus) for type 2 diabetes
via NeLM news - Diabetes on 6/7/08
The July edition of the Drug and Therapeutics Bulletin (DTB) features a review of three new treatments for type 2 diabetes: exenatide (Byetta®), sitagliptin (Januvia®), and vildagliptin (Galvus®). It discusses the incretins and glucose metabolism, examines the trial data and its limitations, and looks at national guidelines....
FDA panel says diabetes drugs need cardiovascular risk studies
via NeLM news - Diabetes on 2/7/08
PharmaTimes reports that the US Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee has advised US regulators they should insist that studies on new diabetes treatments include much more data on the potential heart risks of the treatments....
FDA to consider necessity of cardiovascular studies for diabetes drugs
via NeLM news - Diabetes on 30/6/08
According to a report in the Wall Street Journal, the US FDA is summoning a panel of experts to consider whether pharmaceutical companies should be required to study the cardiovascular effects of diabetes drugs prior to approval. The report points out that cardiovascular endpoints are relatively rare and therefore large, long-term studies would be required to demonstrate any statistically significant effects; this could slow the development of new drugs and would increase costs.
FDA approves PrandiMet (repaglinide and metformin) for type 2 diabetes
via NeLM news - Diabetes on 24/6/08
According to BioSpace, the FDA has approved PrandiMet™ (repaglinide and metformin) tablets as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus who are already treated with a meglitinide [the drug class that repaglinide belongs to] and metformin or who have inadequate glycaemic control on a meglitinide alone or metformin alone. Please see the link above for details.
Benefits of intensive glucose control in older type 2 diabetics limited by co-morbidity
via NeLM news - Diabetes on 30/6/08
A decision analysis study suggests that for older patients with type 2 diabetes, intensive blood glucose control becomes less useful with increasing co-morbidity and functional impairment; chronological age alone, however, was not useful for predicting benefit. Intensive control of blood glucose has been shown to be beneficial in type 1 diabetes, and may also improve outcomes in type 2 diabetes....
25 June 2008 - My life
via NLH Diabetes Specialist Library Whats New by Diane Clay on 25/6/08
How to manage your diabetes as a young adult, moving away from home, taking control of your life
NPC iblog: Putting blood glucose control in type 2 diabetes into perspective
via NeLM news - Diabetes on 16/6/08
The National Prescribing Centre have published an iblog discussing a “Perspective” article published in the New England Journal of Medicine, that discusses the implications of ACCORD and ADVANCE studies, alongside some other major clinical studies that evaluated the benefits of reducing risk factors, such as blood lipids, blood pressure and blood glucose levels on preventing cardiovascular (CV) disease....
Antipsychotic agents and diabetes: meta-analysis plus study data on aripiprazole
via NeLM news - Diabetes by nelm@gstt.nhs.uk on 15/6/08
Second-generation antipsychotic drugs are associated with a small increase in risk of diabetes compared to first-generation drugs, according to a meta-analysis, although retrospective analysis of data from a clinical trial suggests that an increased risk with aripiprazole may be less likely....
15 June 2008 - Interesting new diabetes papers April 2008
via NLH Diabetes Specialist Library Whats New on 15/6/08
The latest edition of Dr Roger Gadsbys bulletin is now available
11 June 2008 - Diabetic retinopathy screening
via NLH Diabetes Specialist Library Whats New on 11/6/08
Statement published by the Department of Health on 3 April 2008
11 June 2008 - Joint Position Statement - Integrated Care in the Reforming NHS
via NLH Diabetes Specialist Library Whats New on 11/6/08
A joint publication by Diabetes UK, the Association of British Clinical Diabetologists (ABCD), the Primary Care Diabetes Society (PCDS), Community Diabetes Consultants (CDC) and the RCN Diabetes Nursing Forum issued in December 2007
via NeLM news - Diabetes on 7/7/08
The latest edition of MeReC Monthly reviews the use of routine self-monitoring of blood glucose (SMBG), noting that two recent studies (ESMON and DiGEM economic analysis) have reinforced the view that it is unlikely to be beneficial in patients with type 2 diabetes who are not treated with insulin and may worsen quality of life and waste NHS resources. Therefore it should be reserved for patients treated with insulin and for non-insulin treated patients in specific circumstances, as recommended in recent NICE guidance on type 2 diabetes (see link).
SMC accepts restricted use of Eucreas tablets (vildagliptin 50mg + metformin 850mg or 1000mg) for type 2 diabetes
via NeLM news - Diabetes 7/7/08
Following a review of an abbreviated submission (used for new formulations at same or lesser cost, and new tablet strength or size), the Scottish Medicines Consortium (SMC) has accepted for restricted use within NHS Scotland, Eucreas® tablets (vildagliptin 50mg/metformin 850mg and vildagliptin 50mg /metformin 1000mg). ...
Meta-analysis: Pregabalin for painful diabetic neuropathy
via NeLM news - Diabetes on 6/7/08
Pregabalin is effective for treatment of painful diabetic neuropathy across its usual dose range, according to a meta-analysis sponsored by the drug's manufacturer and part-authored by company employees. A number of controlled trials have been carried out with pregabalin in patients with painful diabetic neuropathy, however they have used different dose regimens: this analysis was carried out to evaluate the drug's efficacy and safety in this condition at all effective doses....
DTB: exenatide (Byetta), sitagliptin (Januvia), and vildagliptin (Galvus) for type 2 diabetes
via NeLM news - Diabetes on 6/7/08
The July edition of the Drug and Therapeutics Bulletin (DTB) features a review of three new treatments for type 2 diabetes: exenatide (Byetta®), sitagliptin (Januvia®), and vildagliptin (Galvus®). It discusses the incretins and glucose metabolism, examines the trial data and its limitations, and looks at national guidelines....
FDA panel says diabetes drugs need cardiovascular risk studies
via NeLM news - Diabetes on 2/7/08
PharmaTimes reports that the US Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee has advised US regulators they should insist that studies on new diabetes treatments include much more data on the potential heart risks of the treatments....
FDA to consider necessity of cardiovascular studies for diabetes drugs
via NeLM news - Diabetes on 30/6/08
According to a report in the Wall Street Journal, the US FDA is summoning a panel of experts to consider whether pharmaceutical companies should be required to study the cardiovascular effects of diabetes drugs prior to approval. The report points out that cardiovascular endpoints are relatively rare and therefore large, long-term studies would be required to demonstrate any statistically significant effects; this could slow the development of new drugs and would increase costs.
FDA approves PrandiMet (repaglinide and metformin) for type 2 diabetes
via NeLM news - Diabetes on 24/6/08
According to BioSpace, the FDA has approved PrandiMet™ (repaglinide and metformin) tablets as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus who are already treated with a meglitinide [the drug class that repaglinide belongs to] and metformin or who have inadequate glycaemic control on a meglitinide alone or metformin alone. Please see the link above for details.
Benefits of intensive glucose control in older type 2 diabetics limited by co-morbidity
via NeLM news - Diabetes on 30/6/08
A decision analysis study suggests that for older patients with type 2 diabetes, intensive blood glucose control becomes less useful with increasing co-morbidity and functional impairment; chronological age alone, however, was not useful for predicting benefit. Intensive control of blood glucose has been shown to be beneficial in type 1 diabetes, and may also improve outcomes in type 2 diabetes....
25 June 2008 - My life
via NLH Diabetes Specialist Library Whats New by Diane Clay on 25/6/08
How to manage your diabetes as a young adult, moving away from home, taking control of your life
NPC iblog: Putting blood glucose control in type 2 diabetes into perspective
via NeLM news - Diabetes on 16/6/08
The National Prescribing Centre have published an iblog discussing a “Perspective” article published in the New England Journal of Medicine, that discusses the implications of ACCORD and ADVANCE studies, alongside some other major clinical studies that evaluated the benefits of reducing risk factors, such as blood lipids, blood pressure and blood glucose levels on preventing cardiovascular (CV) disease....
Antipsychotic agents and diabetes: meta-analysis plus study data on aripiprazole
via NeLM news - Diabetes by nelm@gstt.nhs.uk on 15/6/08
Second-generation antipsychotic drugs are associated with a small increase in risk of diabetes compared to first-generation drugs, according to a meta-analysis, although retrospective analysis of data from a clinical trial suggests that an increased risk with aripiprazole may be less likely....
15 June 2008 - Interesting new diabetes papers April 2008
via NLH Diabetes Specialist Library Whats New on 15/6/08
The latest edition of Dr Roger Gadsbys bulletin is now available
11 June 2008 - Diabetic retinopathy screening
via NLH Diabetes Specialist Library Whats New on 11/6/08
Statement published by the Department of Health on 3 April 2008
11 June 2008 - Joint Position Statement - Integrated Care in the Reforming NHS
via NLH Diabetes Specialist Library Whats New on 11/6/08
A joint publication by Diabetes UK, the Association of British Clinical Diabetologists (ABCD), the Primary Care Diabetes Society (PCDS), Community Diabetes Consultants (CDC) and the RCN Diabetes Nursing Forum issued in December 2007
Friday, 6 June 2008
Patients not taking their medication
Diabetes UK research - patients not taking their medication
http://www.nelm.nhs.uk/record%20viewing/viewRecord.aspx?id=593723
http://www.nelm.nhs.uk/record%20viewing/viewRecord.aspx?id=593723
Labels:
education,
self monitoring
Friday, 23 May 2008
BIG 4 diabetes articles in the last fortnight
-We have full text access to BMJ, NEJM and JAMA
-Full text access to The Lancet is available two months after publication. Articles published within the last two months are available via interlibrary loan
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study
...type 2 diabetes in people with impaired glucose tolerance, but how long these benefits extend beyond the period of active intervention, and whether such interventions reduce the risk of cardiovascular disease (CVD) and mortality, is unclear. We aimed to assess whether intensive lifestyle interventions have a long-term effect on the risk of diabe...
The Lancet - 10:20 AM (48 minutes ago)
Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomised controlled trial
...type 2 diabetes.
The Lancet - 10:20 AM (48 minutes ago)
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
...type 2 diabetes mellitus have increased cardiovascular disease risk compared with those without diabetes. Treatment of the residual risk, other than blood pressure and LDL-cholesterol control, remains important as the rate of diabetes increases worldwide. The accelerated atherosclerosis and cardiovascular disease in diabetes is likely to be mult...
The Lancet - 10:20 AM (48 minutes ago)
Diabetes care for south Asian patients: a special case
...type 2 diabetes is rising rapidly worldwide, particularly for south Asian people living in urban areas. South Asian individuals have a four-fold to six-fold greater risk of developing type 2 diabetes, contract the disease at an earlier age, and have higher rates of renal and cardiovascular complications than do other ethnic groups. Although prev...
The Lancet - 10:20 AM (48 minutes ago)
Lifestyle intervention, diabetes, and cardiovascular disease
...type 2 diabetes was first proposed in 1921 by Elliot Joslin who wrote: “There are entirely too many diabetic patients in the country…Therefore, it is proper at the present time to devote attention not alone to treatment, but still more, as in the campaign against the typhoid fever, to prevention. The results may not be quite so striking or as im...
The Lancet - 10:20 AM (48 minutes ago)
Halting the accelerating epidemic of type 1 diabetes
...type 1 diabetes has been steadily increasing worldwide since the middle of the 20th century. The increase has so far been linear and predictable. However, in today's Lancet Valma Harjutsalo and colleagues show that in Finland, which has the highest incidence of type 1 diabetes in the world, the incidence predicted for 2010 on the basis of data f...
The Lancet - 10:20 AM (48 minutes ago)
Profile: Jean Claude Mbanya: fighting diabetes in Africa
...advocates for diabetes in Africa, almost ended up as a chemical engineer. As he prepared to graduate from high school in Cameroon, Mbanya had a scholarship in hand to study chemical engineering in the USA. But at the urging of his father—a local chief who had diabetes and had long dreamed of becoming a doctor—Mbanya went to the capital city, to ...
The Lancet - 10:20 AM (48 minutes ago)
Book: A meeting point for cardiologists and diabetologists
...years for diabetes. Heart disease accounts for between two-thirds and three-quarters of all deaths in type 2 diabetes, and is the leading cause of death in type 1, not least because it abolishes the premenopausal protection from coronary disease enjoyed by women. 30 years ago, these effects attracted less attention: a coronary epidemic was sweep...
The Lancet - 10:20 AM (48 minutes ago)
Statins and diabetes – Authors' reply
...people with diabetes whose baseline LDL cholesterol concentration was 2·6 mmol/L or less. As previously reported, reducing LDL cholesterol with statin therapy by a further 1 mmol/L in this group resulted in a significant 32% relative reduction in the incidence of major vascular events (136 [9·8%] vs 170 [12·2%], rate ratio 0·68; p=0·02, webfigur...
The Lancet - 10:20 AM (48 minutes ago)
Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study
...type 1 diabetes worldwide, reaching 40 per 100 000 people per year in the 1990s. Our aim was to assess the temporal trend in type 1 diabetes incidence since 2000 in Finnish children aged younger than 15 years and to predict the number of cases of type 1 diabetes in the future.
The Lancet - 10:20 AM (48 minutes ago)
Statins and diabetes
...patients with diabetes (Jan 12, p 117) raises the question as to whether all patients with diabetes should be on statins.
The Lancet - 10:20 AM (48 minutes ago)
The global challenge of diabetes
...annual American Diabetes Association Scientific Sessions taking place between June 6–10 in San Francisco, much of the focus in this week's Lancet is on the link between diabetes mellitus and heart disease.
The Lancet - 10:20 AM (48 minutes ago)
Type 1 diabetes, hyperglycaemia, and the heart
...Type 1 diabetes is associated with a substantially increased risk of cardiovascular disease that might not always be appreciated in view of the fairly young age of patients with this condition. In fact, in type 1 diabetes, the heart is subject to a variety of pathological insults, including accelerated atherosclerosis, cardiac autonomic neuropat...
The Lancet - 10:20 AM (48 minutes ago)
Intensive insulin therapy in newly diagnosed type 2 diabetes
...type 2 diabetes is characterised by worsening hyperglycaemia and progressive deterioration in function of the insulin-secreting pancreatic β cells. Despite intense investigative efforts, the pathophysiological basis underlying β-cell dysfunction (and the concomitant loss of β-cell mass) remains unclear. Nevertheless, the central importance of de...
The Lancet - 10:20 AM (48 minutes ago)
Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial
...type 2 diabetes might improve β-cell function and result in extended glycaemic remissions. We did a multicentre, randomised trial to compare the effects of transient intensive insulin therapy (continuous subcutaneous insulin infusion [CSII] or multiple daily insulin injections [MDI]) with oral hypoglycaemic agents on β-cell function and diabetes...
The Lancet - 10:20 AM (48 minutes ago)
[EDITORIALS] Self monitoring of blood glucose in type 2 diabetes
BMJ current issue - 11:56 PM (11 hours ago)
[RESEARCH] Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis
...type 2 diabetes: (a) screening for type 2 diabetes to enable early detection and treatment, (b) screening for type 2 diabetes and impaired glucose tolerance, intervening with lifestyle interventions in those with a diagnosis of impaired glucose tolerance to delay or prevent diabetes, (c) as for (b) but with pharmacological interventions, and (d)...
BMJ current issue - 11:56 PM (11 hours ago)
[RESEARCH] Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial
...type 2 diabetes mellitus. Design Prospective randomised controlled trial of self monitoring versus no monitoring (control). Setting Hospital diabetes clinics. Participants 184 (111 men) people aged <70 class="entry-source-title-link" href="http://www.google.com/reader/view/feed/http://www.bmj.com/rss/current.xml" target="_blank" closure_hashcode_="295">BMJ current issue - 11:56 PM (11 hours ago)
[EDITORIALS] Screening for and prevention of type 2 diabetes
BMJ current issue - 11:56 PM (11 hours ago)
[RESEARCH] Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial
...type 2 diabetes. Design Incremental cost utility analysis from a healthcare perspective. Data on resource use from the randomised controlled diabetes glycaemic education and monitoring (DiGEM) trial covered 12 months before baseline and 12 months of trial follow-up. Quality of life was measured at baseline and 12 months using the EuroQol EQ-5D q...
BMJ current issue - 11:56 PM (11 hours ago)
CORRESPONDENCE: Multifactorial Intervention and Mortality in Type 2 Diabetes
To the Editor: In their article on aggressive multiagent treatment of risk factors for diabetic complications, Gæde et al. (Feb. ...
New England Journal of Medicine - May 21, 2008 (2 days ago)
ORIGINAL CONTRIBUTION: Association Between Circulating Oxidized Low-Density Lipoprotein and Incidence of the Metabolic Syndrome
Context Experimental data support the hypothesis that oxidized low-density lipoprotein (LDL) is associated with the metabolic syndrome. However, this hypothesis has not been tested in humans. Objective To establish the relation of oxidized LDL with metabolic syndrome in the general community. Design, Setting, and Participants The Coronary Artery...
JAMA current issue - May 20, 2008 (3 days ago)
LETTERS: Surgical vs Behavioral Therapy for Weight Loss in Patients With Type 2 Diabetes
JAMA current issue - May 13, 2008 9:27 PM
LETTERS: Surgical vs Behavioral Therapy for Weight Loss in Patients With Type 2 Diabetes--Reply
JAMA current issue - May 13, 2008 9:27 PM
[NEWS] Prevalence of pre-existing diabetes in pregnancy doubled in seven years in a Californian population
BMJ current issue - May 8, 2008 11:40 PM
-Full text access to The Lancet is available two months after publication. Articles published within the last two months are available via interlibrary loan
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study
...type 2 diabetes in people with impaired glucose tolerance, but how long these benefits extend beyond the period of active intervention, and whether such interventions reduce the risk of cardiovascular disease (CVD) and mortality, is unclear. We aimed to assess whether intensive lifestyle interventions have a long-term effect on the risk of diabe...
The Lancet - 10:20 AM (48 minutes ago)
Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomised controlled trial
...type 2 diabetes.
The Lancet - 10:20 AM (48 minutes ago)
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
...type 2 diabetes mellitus have increased cardiovascular disease risk compared with those without diabetes. Treatment of the residual risk, other than blood pressure and LDL-cholesterol control, remains important as the rate of diabetes increases worldwide. The accelerated atherosclerosis and cardiovascular disease in diabetes is likely to be mult...
The Lancet - 10:20 AM (48 minutes ago)
Diabetes care for south Asian patients: a special case
...type 2 diabetes is rising rapidly worldwide, particularly for south Asian people living in urban areas. South Asian individuals have a four-fold to six-fold greater risk of developing type 2 diabetes, contract the disease at an earlier age, and have higher rates of renal and cardiovascular complications than do other ethnic groups. Although prev...
The Lancet - 10:20 AM (48 minutes ago)
Lifestyle intervention, diabetes, and cardiovascular disease
...type 2 diabetes was first proposed in 1921 by Elliot Joslin who wrote: “There are entirely too many diabetic patients in the country…Therefore, it is proper at the present time to devote attention not alone to treatment, but still more, as in the campaign against the typhoid fever, to prevention. The results may not be quite so striking or as im...
The Lancet - 10:20 AM (48 minutes ago)
Halting the accelerating epidemic of type 1 diabetes
...type 1 diabetes has been steadily increasing worldwide since the middle of the 20th century. The increase has so far been linear and predictable. However, in today's Lancet Valma Harjutsalo and colleagues show that in Finland, which has the highest incidence of type 1 diabetes in the world, the incidence predicted for 2010 on the basis of data f...
The Lancet - 10:20 AM (48 minutes ago)
Profile: Jean Claude Mbanya: fighting diabetes in Africa
...advocates for diabetes in Africa, almost ended up as a chemical engineer. As he prepared to graduate from high school in Cameroon, Mbanya had a scholarship in hand to study chemical engineering in the USA. But at the urging of his father—a local chief who had diabetes and had long dreamed of becoming a doctor—Mbanya went to the capital city, to ...
The Lancet - 10:20 AM (48 minutes ago)
Book: A meeting point for cardiologists and diabetologists
...years for diabetes. Heart disease accounts for between two-thirds and three-quarters of all deaths in type 2 diabetes, and is the leading cause of death in type 1, not least because it abolishes the premenopausal protection from coronary disease enjoyed by women. 30 years ago, these effects attracted less attention: a coronary epidemic was sweep...
The Lancet - 10:20 AM (48 minutes ago)
Statins and diabetes – Authors' reply
...people with diabetes whose baseline LDL cholesterol concentration was 2·6 mmol/L or less. As previously reported, reducing LDL cholesterol with statin therapy by a further 1 mmol/L in this group resulted in a significant 32% relative reduction in the incidence of major vascular events (136 [9·8%] vs 170 [12·2%], rate ratio 0·68; p=0·02, webfigur...
The Lancet - 10:20 AM (48 minutes ago)
Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study
...type 1 diabetes worldwide, reaching 40 per 100 000 people per year in the 1990s. Our aim was to assess the temporal trend in type 1 diabetes incidence since 2000 in Finnish children aged younger than 15 years and to predict the number of cases of type 1 diabetes in the future.
The Lancet - 10:20 AM (48 minutes ago)
Statins and diabetes
...patients with diabetes (Jan 12, p 117) raises the question as to whether all patients with diabetes should be on statins.
The Lancet - 10:20 AM (48 minutes ago)
The global challenge of diabetes
...annual American Diabetes Association Scientific Sessions taking place between June 6–10 in San Francisco, much of the focus in this week's Lancet is on the link between diabetes mellitus and heart disease.
The Lancet - 10:20 AM (48 minutes ago)
Type 1 diabetes, hyperglycaemia, and the heart
...Type 1 diabetes is associated with a substantially increased risk of cardiovascular disease that might not always be appreciated in view of the fairly young age of patients with this condition. In fact, in type 1 diabetes, the heart is subject to a variety of pathological insults, including accelerated atherosclerosis, cardiac autonomic neuropat...
The Lancet - 10:20 AM (48 minutes ago)
Intensive insulin therapy in newly diagnosed type 2 diabetes
...type 2 diabetes is characterised by worsening hyperglycaemia and progressive deterioration in function of the insulin-secreting pancreatic β cells. Despite intense investigative efforts, the pathophysiological basis underlying β-cell dysfunction (and the concomitant loss of β-cell mass) remains unclear. Nevertheless, the central importance of de...
The Lancet - 10:20 AM (48 minutes ago)
Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial
...type 2 diabetes might improve β-cell function and result in extended glycaemic remissions. We did a multicentre, randomised trial to compare the effects of transient intensive insulin therapy (continuous subcutaneous insulin infusion [CSII] or multiple daily insulin injections [MDI]) with oral hypoglycaemic agents on β-cell function and diabetes...
The Lancet - 10:20 AM (48 minutes ago)
[EDITORIALS] Self monitoring of blood glucose in type 2 diabetes
BMJ current issue - 11:56 PM (11 hours ago)
[RESEARCH] Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis
...type 2 diabetes: (a) screening for type 2 diabetes to enable early detection and treatment, (b) screening for type 2 diabetes and impaired glucose tolerance, intervening with lifestyle interventions in those with a diagnosis of impaired glucose tolerance to delay or prevent diabetes, (c) as for (b) but with pharmacological interventions, and (d)...
BMJ current issue - 11:56 PM (11 hours ago)
[RESEARCH] Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial
...type 2 diabetes mellitus. Design Prospective randomised controlled trial of self monitoring versus no monitoring (control). Setting Hospital diabetes clinics. Participants 184 (111 men) people aged <70 class="entry-source-title-link" href="http://www.google.com/reader/view/feed/http://www.bmj.com/rss/current.xml" target="_blank" closure_hashcode_="295">BMJ current issue - 11:56 PM (11 hours ago)
[EDITORIALS] Screening for and prevention of type 2 diabetes
BMJ current issue - 11:56 PM (11 hours ago)
[RESEARCH] Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial
...type 2 diabetes. Design Incremental cost utility analysis from a healthcare perspective. Data on resource use from the randomised controlled diabetes glycaemic education and monitoring (DiGEM) trial covered 12 months before baseline and 12 months of trial follow-up. Quality of life was measured at baseline and 12 months using the EuroQol EQ-5D q...
BMJ current issue - 11:56 PM (11 hours ago)
CORRESPONDENCE: Multifactorial Intervention and Mortality in Type 2 Diabetes
To the Editor: In their article on aggressive multiagent treatment of risk factors for diabetic complications, Gæde et al. (Feb. ...
New England Journal of Medicine - May 21, 2008 (2 days ago)
ORIGINAL CONTRIBUTION: Association Between Circulating Oxidized Low-Density Lipoprotein and Incidence of the Metabolic Syndrome
Context Experimental data support the hypothesis that oxidized low-density lipoprotein (LDL) is associated with the metabolic syndrome. However, this hypothesis has not been tested in humans. Objective To establish the relation of oxidized LDL with metabolic syndrome in the general community. Design, Setting, and Participants The Coronary Artery...
JAMA current issue - May 20, 2008 (3 days ago)
LETTERS: Surgical vs Behavioral Therapy for Weight Loss in Patients With Type 2 Diabetes
JAMA current issue - May 13, 2008 9:27 PM
LETTERS: Surgical vs Behavioral Therapy for Weight Loss in Patients With Type 2 Diabetes--Reply
JAMA current issue - May 13, 2008 9:27 PM
[NEWS] Prevalence of pre-existing diabetes in pregnancy doubled in seven years in a Californian population
BMJ current issue - May 8, 2008 11:40 PM
Diabetes Technology and Therapeutics (2008 vol. 10, part. 8)
We do not have direct access to these articles. They are available via interlibrary loan.
Original Articles
Characterizing Glucose Exposure for Individuals with Normal Glucose Tolerance Using Continuous Glucose Monitoring and Ambulatory Glucose Profile Analysis
Author(s):Mazze , Roger S . ; Strock , Ellie ; Wesley , David ; Borgman , Sarah ; Morgan , Blaine ; Bergenstal , Richard ; Cuddihy , Robert
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:149-159
WellDoc™ ; Mobile Diabetes Management R and omized Controlled Trial : Change in Clinical and Behavioral Outcomes and Patient and Physician Satisfaction
Author(s):Quinn , Charlene C . ; Clough , Suzanne Sysko ; Minor , James M . ; Lender , Dan ; Okafor , Maria C . ; Gruber - Baldini , Ann
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:160-168
Accuracy of Glycemic Measurements in the Critically Ill
Author(s):Slater - MacLean , Linda ; Cembrowski , George ; Chin , Dat ; Shalapay , Carol ; Binette , Tanya ; Hegadoren , Kathy ; Newburn - Cook , Christine
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:169-177
How Would Patients Behave If They Were Continually Informed of Their Blood Glucose Levels ? A Simulation Study Using a "Virtual" Patient
Author(s):Biermann , Eberhard ; Barkhausen , Katharina ; Standl , Eberhard
2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:178-187
Optical Coherence Tomography - Based Continuous Noninvasive Glucose Monitoring in Patients with Diabetes
Author(s):Gabbay , Robert A . ; Sivarajah , Surendra
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:188-193
Real - Time Continuous Glucose Monitoring Together with Telemedical Assistance Improves Glycemic Control and Glucose Stability in Pump - Treated Patients
Author(s):Rigla , Mercedes ; Hern and o , M . Elena ; Gâ ; omez , Enrique J . ; Bruguâ ; es , Eulalia ; Garcâ ; ia - Sâ ; aez , Gema ; Capel , Ismael ; Pons , Belâ ; en ; de Leiva , Alberto
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:194-199
Skin Autofluorescence Increases Postprandially in Human Subjects
Author(s):Stirban , Alin ; Nandrean , Simona ; Negrean , Monica ; Koschinsky , Theodor ; Tschoepe , Diethelm
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:200-205
The IRIS V Study : Pioglitazone Improves Systemic Chronic Inflammation in Patients with Type 2 Diabetes Under Daily Routine Conditions
Author(s):Karagiannis , Efstrathios ; Pfè ; utzner , Andreas ; Forst , Thomas ; Lè ; ubben , Georg ; Roth , Werner ; Grabellus , Martin ; Flannery , Manja ; Schè ; ondorf , Thomas
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:206-212
The Effects of Depression on Diabetes Knowledge , Diabetes Self - Management , and Perceived Control in Indigent Patients with Type 2 Diabetes
Author(s):Egede , Leonard E . ; Ellis , Charles
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:213-219
Quality of Care of a Pharmacist - Managed Diabetes Service Compared to Usual Care in an Indigent Clinic
Author(s):Irons , Brian K . ; Seifert , Charles F . ; Horton , Niambi A .
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:220-226
The Impact of Clinical Trial Design on Cost - Effectiveness Analyses : Illustration from a Published Study of the One - Touch® ; Ultrasmart® ; Blood Glucose Meter for Insulin - Using Diabetes Patients
Tunis , Sandra L . ; Minshall , Michael E .
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:227-231
Original Articles
Characterizing Glucose Exposure for Individuals with Normal Glucose Tolerance Using Continuous Glucose Monitoring and Ambulatory Glucose Profile Analysis
Author(s):Mazze , Roger S . ; Strock , Ellie ; Wesley , David ; Borgman , Sarah ; Morgan , Blaine ; Bergenstal , Richard ; Cuddihy , Robert
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:149-159
WellDoc™ ; Mobile Diabetes Management R and omized Controlled Trial : Change in Clinical and Behavioral Outcomes and Patient and Physician Satisfaction
Author(s):Quinn , Charlene C . ; Clough , Suzanne Sysko ; Minor , James M . ; Lender , Dan ; Okafor , Maria C . ; Gruber - Baldini , Ann
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:160-168
Accuracy of Glycemic Measurements in the Critically Ill
Author(s):Slater - MacLean , Linda ; Cembrowski , George ; Chin , Dat ; Shalapay , Carol ; Binette , Tanya ; Hegadoren , Kathy ; Newburn - Cook , Christine
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:169-177
How Would Patients Behave If They Were Continually Informed of Their Blood Glucose Levels ? A Simulation Study Using a "Virtual" Patient
Author(s):Biermann , Eberhard ; Barkhausen , Katharina ; Standl , Eberhard
2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:178-187
Optical Coherence Tomography - Based Continuous Noninvasive Glucose Monitoring in Patients with Diabetes
Author(s):Gabbay , Robert A . ; Sivarajah , Surendra
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:188-193
Real - Time Continuous Glucose Monitoring Together with Telemedical Assistance Improves Glycemic Control and Glucose Stability in Pump - Treated Patients
Author(s):Rigla , Mercedes ; Hern and o , M . Elena ; Gâ ; omez , Enrique J . ; Bruguâ ; es , Eulalia ; Garcâ ; ia - Sâ ; aez , Gema ; Capel , Ismael ; Pons , Belâ ; en ; de Leiva , Alberto
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:194-199
Skin Autofluorescence Increases Postprandially in Human Subjects
Author(s):Stirban , Alin ; Nandrean , Simona ; Negrean , Monica ; Koschinsky , Theodor ; Tschoepe , Diethelm
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:200-205
The IRIS V Study : Pioglitazone Improves Systemic Chronic Inflammation in Patients with Type 2 Diabetes Under Daily Routine Conditions
Author(s):Karagiannis , Efstrathios ; Pfè ; utzner , Andreas ; Forst , Thomas ; Lè ; ubben , Georg ; Roth , Werner ; Grabellus , Martin ; Flannery , Manja ; Schè ; ondorf , Thomas
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:206-212
The Effects of Depression on Diabetes Knowledge , Diabetes Self - Management , and Perceived Control in Indigent Patients with Type 2 Diabetes
Author(s):Egede , Leonard E . ; Ellis , Charles
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:213-219
Quality of Care of a Pharmacist - Managed Diabetes Service Compared to Usual Care in an Indigent Clinic
Author(s):Irons , Brian K . ; Seifert , Charles F . ; Horton , Niambi A .
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:220-226
The Impact of Clinical Trial Design on Cost - Effectiveness Analyses : Illustration from a Published Study of the One - Touch® ; Ultrasmart® ; Blood Glucose Meter for Insulin - Using Diabetes Patients
Tunis , Sandra L . ; Minshall , Michael E .
ISSUE:2008 ; VOL 10 ; PART 3 (2008/06/01)
Page:227-231
Thursday, 8 May 2008
eCAB Week in Review 25/4/08
National Prescribing Centre (NPC): www.npc.co.uk
On the Horizon PostLaunch Update. Vildagliptin for type 2
diabetes-April 2008 (NHSnet connection required)
NPCi Blog : www.npci.org.uk/blog/
MeReC Rapid Review: Self-monitoring in type 2 diabetes not
treated with insulin usually doesn't help, can worsen quality of life,
and may waste NHS resources
BMJ: bmj.com/
Editorials: Screening and prevention for type 2 diabetes
European Agency for the Evaluation of Medicinal Products (EMEA): www.emea.europa.eu/
EMEA adopts positive opinions for:
sitagliptin phosphate monohydrate / metformin hydrochloride for
the treatment of type 2 diabetes mellitus
HTA: www.hta.nhsweb.nhs.uk/
The clinical effectiveness of diabetes education models for Type
2 diabetes: a systematic review
National electronic Library for Medicines (NeLM): www.nelm.nhs.uk
Efficacy and cost effectiveness of self monitoring of blood
glucose in patients with newly diagnosed type 2 diabetes
On the Horizon PostLaunch Update. Vildagliptin for type 2
diabetes-April 2008 (NHSnet connection required)
NPCi Blog : www.npci.org.uk/blog/
MeReC Rapid Review: Self-monitoring in type 2 diabetes not
treated with insulin usually doesn't help, can worsen quality of life,
and may waste NHS resources
BMJ: bmj.com/
Editorials: Screening and prevention for type 2 diabetes
European Agency for the Evaluation of Medicinal Products (EMEA): www.emea.europa.eu/
EMEA adopts positive opinions for:
sitagliptin phosphate monohydrate / metformin hydrochloride for
the treatment of type 2 diabetes mellitus
HTA: www.hta.nhsweb.nhs.uk/
The clinical effectiveness of diabetes education models for Type
2 diabetes: a systematic review
National electronic Library for Medicines (NeLM): www.nelm.nhs.uk
Efficacy and cost effectiveness of self monitoring of blood
glucose in patients with newly diagnosed type 2 diabetes
Friday, 25 April 2008
Self monitoring of blood glucose in patients with type 2 diabetes
BMJ.com
The NHS is spending £100 million a year to help people with non-insulin treated type 2 diabetes monitor their own blood sugar levels, but the process is more likely to make them depressed than provide any long term health benefits. Access the two research papers and editorial by following the links from bmj.com's Research channel. There are also Rapid Responses to these online first papers.
Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial
Responses
Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial
The NHS is spending £100 million a year to help people with non-insulin treated type 2 diabetes monitor their own blood sugar levels, but the process is more likely to make them depressed than provide any long term health benefits. Access the two research papers and editorial by following the links from bmj.com's Research channel. There are also Rapid Responses to these online first papers.
Self monitoring of blood glucose in type 2 diabetes
Responses
Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial
Responses
Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial
Subscribe to:
Posts (Atom)
